| Carl Fredrik Von Trampe, MD | |
|
25825 Vermont Ave, Harbor City, CA 90710-3518 | |
| (310) 325-5111 | |
| (626) 405-6768 |
| Full Name | Carl Fredrik Von Trampe |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 25825 Vermont Ave, Harbor City, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497953244 | NPI | - | NPPES |
| 00A781970 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A78197 (California) | Secondary |
| 207P00000X | Emergency Medicine | M-1929 (Guam) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guam Regional Medical City | Dededo, GU | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guam Healthcare Development Incorporated | 9234351776 | 124 |
News Archive
The move was announced by federal Health Minister Tanya Plibersek at the weekend. It is claimed to provide $345.9m over three years to reduce the long waiting lists for public dental treatment. This could benefit 400,000 people. Ms Plibersek also announced that the Voluntary Dental Graduate Year Program will be increased from 50 to 100 placements per year by 2016 at a cost of $35.7 million over three years. "This funding boost will provide practice experience and professional development opportunities, including in under-serviced areas, to additional dental graduates," she said.
"Women, particularly those living in mountain regions in developing countries, are facing disproportionately high risks to their livelihoods and health from climate change, as well as associated risks such as human trafficking, according to a new report from the United Nations Environment Programme (UNEP)," released at the U.N. Climate Change Conference in Durban, South Africa, the UNEP News Centre reports.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRA™ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.
› Verified 1 days ago
| Entity Name | Guam Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366519027 PECOS PAC ID: 5890781694 Enrollment ID: O20040426000038 |
News Archive
The move was announced by federal Health Minister Tanya Plibersek at the weekend. It is claimed to provide $345.9m over three years to reduce the long waiting lists for public dental treatment. This could benefit 400,000 people. Ms Plibersek also announced that the Voluntary Dental Graduate Year Program will be increased from 50 to 100 placements per year by 2016 at a cost of $35.7 million over three years. "This funding boost will provide practice experience and professional development opportunities, including in under-serviced areas, to additional dental graduates," she said.
"Women, particularly those living in mountain regions in developing countries, are facing disproportionately high risks to their livelihoods and health from climate change, as well as associated risks such as human trafficking, according to a new report from the United Nations Environment Programme (UNEP)," released at the U.N. Climate Change Conference in Durban, South Africa, the UNEP News Centre reports.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRA™ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.
› Verified 1 days ago
| Entity Name | Guam Healthcare Development Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326447939 PECOS PAC ID: 9234351776 Enrollment ID: O20150326000266 |
News Archive
The move was announced by federal Health Minister Tanya Plibersek at the weekend. It is claimed to provide $345.9m over three years to reduce the long waiting lists for public dental treatment. This could benefit 400,000 people. Ms Plibersek also announced that the Voluntary Dental Graduate Year Program will be increased from 50 to 100 placements per year by 2016 at a cost of $35.7 million over three years. "This funding boost will provide practice experience and professional development opportunities, including in under-serviced areas, to additional dental graduates," she said.
"Women, particularly those living in mountain regions in developing countries, are facing disproportionately high risks to their livelihoods and health from climate change, as well as associated risks such as human trafficking, according to a new report from the United Nations Environment Programme (UNEP)," released at the U.N. Climate Change Conference in Durban, South Africa, the UNEP News Centre reports.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRA™ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carl Fredrik Von Trampe, MD 393 E Walnut St, 3rd Floor - Phr Systems, Pasadena, CA 91188-0001 Ph: (626) 405-7914 | Carl Fredrik Von Trampe, MD 25825 Vermont Ave, Harbor City, CA 90710-3518 Ph: (310) 325-5111 |
News Archive
The move was announced by federal Health Minister Tanya Plibersek at the weekend. It is claimed to provide $345.9m over three years to reduce the long waiting lists for public dental treatment. This could benefit 400,000 people. Ms Plibersek also announced that the Voluntary Dental Graduate Year Program will be increased from 50 to 100 placements per year by 2016 at a cost of $35.7 million over three years. "This funding boost will provide practice experience and professional development opportunities, including in under-serviced areas, to additional dental graduates," she said.
"Women, particularly those living in mountain regions in developing countries, are facing disproportionately high risks to their livelihoods and health from climate change, as well as associated risks such as human trafficking, according to a new report from the United Nations Environment Programme (UNEP)," released at the U.N. Climate Change Conference in Durban, South Africa, the UNEP News Centre reports.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
Galenea Corp. has been awarded a highly competitive grant from the National Institute of Mental Health in response to the solicitation "Recovery Act Limited Competition: NIH Director's Opportunity for Research in Five Thematic Areas (RC4)," funded by the American Recovery and Reinvestment Act of 2009. Galenea has developed an innovative technology platform, termed MANTRA™ (Multiwell, Automated NeuroTRansmission Assay) that enables high-throughput screening for the identification of small molecule modulators of synaptic transmission.
› Verified 1 days ago
Kimberly M. Preciado, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Jennifer T. Donson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-517-3150 | |
Sasan Jahan-parwar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Vicente D. Sanchez, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Dr. Vivian C Tsai, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Linda Chang Park, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 | |
Richard C. Biscay, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 25825 Vermont Ave, Harbor City, CA 90710 Phone: 310-325-5111 |